Safety and effectiveness of prophylactic anticoagulation for prevention of COVID-19 mortality: A nationwide cohort study of hospitalised patients in the US
Christopher T. Rentsch(University of London), Matthew S. Freiberg(Vanderbilt University), Evan L. Brittain(Vanderbilt University Medical Center), Yi‐Lwun Ho(National Taiwan University Hospital), Walid F. Gellad(University of Pittsburgh), Po‐Lai Ho(Chinese University of Hong Kong), Paul A. Heidenreich(Palo Alto University), Daniel Jacobson(Oak Ridge National Laboratory), Charles Alcorn(University of Pittsburgh), Stephen Evans(London School of Hygiene & Tropical Medicine), Melissa Skanderson(United States Department of Veterans Affairs), Svetlana Eden(Vanderbilt University Medical Center), Dianne L. Atkins(Atkins (United States)), Farah Kidwai‐Khan(United States Department of Veterans Affairs), Michael F Lann(University of Pittsburgh), Robert A. Greevy(Vanderbilt University Medical Center), Laurie A. Tomlinson(London School of Hygiene & Tropical Medicine), Anita Justice(John Radcliffe Hospital), J. Tate, IJ Douglas, J. T. King, Sanghita Kundu, Joshua A. Beckman(Clinical Research Institute)
Pharmacoepidemiology and Drug Safety
January 1, 2021
Cited by 0
Related Papers
Forecasting the Future of Cardiovascular Disease in the United States
|Circulation|2011|3.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Forecasting the Impact of Heart Failure in the United States
|Circulation Heart Failure|2013|2.8k
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
|Journal of the American College of Cardiology|2018|2.6k